Homocysteine and Malondialdehyde as Predictors of Restenosis Following Percutaneous Coronary Intervention

Abstract

Restenosis is one of the major adverse outcomes of Percutaneous CoronaryIntervention (PCI). Previous studies have shown conflicting reports for homocysteine as a predictor of restenosis following PCI. The conflicting reports may be due to oxidative factors (stimulation of polymorphonuclear leukocyte [PMNL]-induced reactive oxygen species generation, xanthine-xanthine oxidase, and arachidonic acid metabolism) other than homocysteine which could cause endothelial cell dysfunction leading to restenosis.Malondialdehyde (MDA), a lipid peroxidation product, is a marker for oxidative stress and is related to all oxidative factors. Therefore, it is possible that serum MDA may be a better predictor of restenosis than plasma homocysteine. The purpose of this study is to determine whether or not the pre-procedural serum MDA and plasma homocysteine levels are elevated in patients who develop restenosis post PCI.The study included fifty-one patients undergoing elective PCI who consented to participate in a protocol that was approved by the Ethics Committee of the University of Saskatchewan. Homocysteine and malondialdehyde were measured in the plasma and serum respectively. Blood samples were collected pre-procedural, 0 time, 8 hours, 24 hours, and 6 months post-procedure. Exercise tolerance tests were performed at two weeks, and six months post-procedure to determine if there was any evidence of restenosis.The results of the study showed that pre-procedural values of plasma homocysteine in the restenosis and non-restenosis groups were 10.37 ± 0.46 and 10.73 ± 0.49 respectively. These values were not significantly different (p=0.60) between the groups. The pre-procedural levels of plasma homocysteine were not significantly ii different (p=0.08) from the post-PCI values of those patients who did not develop restenosis at the 6-month time interval. However, the pre-procedural levels of plasma homocysteine were significantly different from the post-PCI values of those patients in the restenosis group at the 24hr (p=0.04) and 6-month (p=0.002) time intervals. In the restenosis group there was a significant increase (24%) after six months in the values of homocysteine from the pre-procedural levels. Thus, this indicates that restenosis is associated with higher post-PCI levels of homocysteine.The pre-procedural levels of serum MDA in the restenosis and non-restenosis groups were 0.124± 0.16 and 0.147± 0.02 respectively. There was no significant difference (p=0.60) between the two groups. There was also no significant difference The results suggest that pre-procedural levels of plasma homocysteine and serum MDA were not predictors of restenosis following PCI. However, the post-PCI sixmonth levels of both homocysteine and MDA are predictors of restenosis. Moreover, the post-PCI levels of MDA were better predictors of restenosis than the post-PCI levels of homocysteine because the increase in MDA levels were greater at six months than the rise in homocysteine levels at the same time interval.iii ACKNOWLEDGEMENTS

Advanced Glycation End Products:Receptors for Advanced Glycation End Products Axis in Coronary Stent Restenosis: A Prospective Study

“…13 Therefore, the objective of measuring MDA is that it serves as an indirect biomarker of ROS activity. 14 Collectively, endothelial injury, sRAGE, AGE, and ROS appear predictive of restenosis. In this pilot study, we hypothesize that post-PCI ISR is associated with low serum levels of sRAGE, high serum levels of AGE, and high AGE/sRAGE ratios.…”

Inverse Association between Cardiac Troponin-I and Soluble Receptor for Advanced Glycation End Products in Patients with Non-ST-Segment Elevation Myocardial Infarction

“…Increased levels of oxygen radicals have been reported in patients with ACS. 46,47 The cellular membrane damage from oxygen radicals 24,25,31 may result in the release of various biomarkers including cTnI. A negative correlation between sRAGE and cTnI suggests that the severity of cardiac damage varies inversely with the levels of sRAGE.…”

Evaluation of Homocysteine and Some Biochemical Parameters in Patients with Coronary Atherosclerosis in Erbil Governorate

“…Diabetes is a significant risk factor for atherosclerosis; the diabetic state promotes oxidative stress mediated by reactive oxygen species, these consume NO and lead to endothelial dysfunction (Libby, Ridker and Maseri, 2002). Hyperglycemia in diabetics may induce dysfunctional endothelium which is involved in the genesis of atherosclerosis (McNair, 2006). Atherosclerosis is considered to be an inflammatory process triggered by response to injury and oxidative stress.…”